ArticleAntimicrobial agents and chemotherapy2020

Targeting CARD9 with Small-Molecule Therapeutics Inhibits Innate Immune Signaling and Inflammatory Response to Pneumocystis carinii β-Glucans.

Theodore J Kottom et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.